Germany, April 7 -- Germany based Bietergemeinschaft ALIUD / STADAPHARM GbR, HEXAL AG has secured contract from DAK-Gesundheit for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient Suninib (exclusively in the effectiveness of 37.5 mg), ATC L01EX01 for the time 01082023 - 31072025. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....